Woodline Partners LP Roivant Sciences Ltd. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Woodline Partners LP holds 6,131,948 shares of ROIV stock, worth $65.5 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
6,131,948
Previous 8,686,476
29.41%
Holding current value
$65.5 Million
Previous $100 Million
27.63%
% of portfolio
0.54%
Previous 0.91%
Shares
10 transactions
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$703 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$663 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$511 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$471 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$378 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.52B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...